Created in 2015, Avara Pharmaceutical Services is a state-of-the-art contract development and manufacturing organization (CDMO) providing both primary formulation and manufacturing, and secondary manufacturing and packaging of small molecules.

Norwalk, CT, September 6, 2016 - Avara Pharmaceutical Services, Inc. (“Avara”) today announced that they have entered into an agreement under which Avara will acquire AstraZeneca’s manufacturing facility located in Avlon, Avonmouth, England.

Norwalk, CT, August 3rd, 2016 –Avara Pharmaceutical Services, Inc. announced that its subsidiary, Avara Norman Pharmaceutical Services, Inc. (“Avara”) entered into an agreement under which Avara will acquire Astellas’s wholly owned manufacturing subsidiary Astellas Pharma Technologies (APT), Inc., located in Norman, Oklahoma.